Term and Conditions

This webpage provides summaries (protocol and results) of Taiho-sponsored interventional clinical trials conducted in patients for medicinal products and indications approved by regulatory authorities in the United States, Europe, or Japan on or after January 15, 2018, in accordance with the IFPMA Principles for Responsible Clinical Trial Data Sharing and Taiho clinical trial information disclosure policy.
As the summaries of clinical studies are findings as of completion of each study, please refer to the latest package insert of each region or country regarding detailed information that has received marketing approval from regulatory authorities.
The information in the synopses of CSRs is not intended to replace the advice of a health care professional. If you have any questions regarding specific symptoms, please consult a health care professional.
This webpage has no intention to promote Taiho’s medicines and the indication.